A Small-Molecule Drug Targeting STAT3 Causes Tumor Regression in Mice

Article navigation

Research Watch| January 09 2020

Online ISSN: 2159-8290

Print ISSN: 2159-8274

2020

American Association for Cancer Research.

Cancer Discov (2020) 10 (1): 11.

Abstract

SD-36, a small-molecule proteolysis-targeting chimera (PROTAC), causes STAT3 degradation in vivo.

2020

American Association for Cancer Research.

You do not currently have access to this content.

Don't already have an account? Register

You could not be signed in. Please check your email address / username and password and try again.